Generex Announces USFDA Approval Of Use Of Company?s Flagship Buccal Insulin Product, Generex Oral-Lyn, Under The Usfda?s Treatment Investigational New Drug (Ind) Program

WORCESTER, MA, September 10, 2009 – Generex Biotechnology Corporation (Nasdaq: GNBT, www.generex.com<http://www.generex.com>), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that...